Background
Stroke occurs when blood flow to the brain is stopped and the brain cells do not receive enough oxygen and begin to die.
1 Once brain cells are damaged, signs and symptoms such as weakness, numbness, aphasia, dysphagia and other symptoms become apparent. 1 Risk factors for stroke include hypertension, cardiac disease, diabetes, smoking and a history of stroke. 1 There are three types of stroke: Transient Ischemic Attack (TIA), ischemic stroke and hemorrhagic stroke. 1 TIA occurs when the blood flow to the brain is blocked for a short period of time, whereas ischemic stroke happens when blood clots or fatty deposits obstruct the blood flow to the brain and hemorrhagic stroke occurs when a blood vessel ruptures in the brain causing blood to exert pressure on the surrounding tissues. 1 One third of stroke patients exhibiting signs and symptoms of aspiration will suffer from pneumonia that requires pharmacological treatment. 12 Pneumonia that occurs during an inpatient episode and was not present on admission is considered to be "hospital-acquired pneumonia" or nosocomial pneumonia. 13 (p.88) "Hospital-acquired pneumonia" commonly results in increased hospital length of stay, with associated costs ranging from USD $13,000 to $16,000 per episode. 3(p.3155) The mortality rate associated with pneumonia is three times higher in patients with dysphagia than in those without this condition. 3 Dysphagia screening is important in early recognition of patients with dysphagia, who are at risk of developing aspiration pneumonia. 14 Dysphagia screening should be performed on patients with acute stroke prior to giving food, fluids or medications. 12 The dysphagia screening is a simple "clinical bedside Video-Fluoroscopy and FEES are considered to be the gold standard for identifying dysphagia and the risk of aspiration. 16 Video-Fluoroscopy provides dynamic images of the bolus during the swallowing process. 16 The bolus can be tracked going through the alimentary tract when contrast materials such as barium sulfate are added. 16 However, expensive equipment is required and the patient is exposed to radiation during this diagnostic test. 14 Nurses have an important role in dysphagia screening; however, nurses must receive training to perform this task successfully. 16 A speech language pathologist performs the dysphagia evaluation process that includes interview with patients/families, "observation, formulation and communication of the results and recommendations" to the physician responsible for the patient.
(para 4)
There are a number of bedside dysphagia screening tools currently in use. 12 The effectiveness of a screening tool is determined by its reliability, validity and clinical utility. 12 Reliability is defined as the ability of the tool to provide consistent and stable results and is measured through a test-retest method. 17 Validity is measured by a tool's sensitivity and specificity. 17 Sensitivity refers to how successful a tool is in detecting patients with dysphagia, whereas specificity assesses how successful a tool is in detecting patients without dysphagia. 18 Positive predictive value is defined as the percentage of stroke patients with positive screening tests that have dysphagia. 18 Negative predictive value refers to the percentage of stroke patients with negative screening tests that do not have dysphagia. 18 "The sensitivity and specificity are inversely proportional." 18(p.47) That is, the higher the value of sensitivity, the lower is the value of specificity. 19 Leder and colleagues assess that while there is no consensus for a specified/defined parameter or value for sensitivity, an effective dysphagia screening tool should have a sensitivity value of 95% or greater. 19 In the late 1990s and early 2000s, there was a movement to evaluate swallow screening tests. 12 There was also an effort to identify the significant factors associated with dysphagia and risk of aspiration (e.g.
abnormal gag reflex, dysphonia, dysarthria and cough after swallow). 12 There was a mounting body of research demonstrating the need for a dysphagia screening tool with sufficient sensitivity, specificity and predictive strength, that could be administered by a frontline healthcare professional. 12 By 2007, the American Heart Association/American Stroke Association guidelines recommended stroke patients be assessed for dysphagia prior to administering food, fluid or medication orally. 12 In 2010, the Joint Commission (TJC) removed the dysphagia screening performance standard because the National Quality Forum (NQF) did not support this measure.
single dysphagia screening tool was identified as being "superior". 12(p.e.25) Therefore, studies published from 2007-2014 will be considered for inclusion in this review. The data chosen indicate the period in which studies were being conducted to assess the validity, sensitivity and specificity of various dysphagia screening tools and identify an evidence-based dysphagia screening tool.
The two dysphagia-screening tools recommended in the guidelines were the Toronto Bedside
Swallowing Screening Test and the 90cc Water Swallow Screening Test. 20 The Toronto Bedside
Swallowing screening test takes approximately 10 minutes to perform. 21 The test is composed of three parts: two parts consists of oral exams and one part tests the patient's ability to swallow 50 cc of water.
The oral exam consists of pharyngeal sensation, tongue movement and dysphonia. 21 Training is available via an online module for hospitals interested in implementing this tool and training their staff. 21 The training takes about four hours and all nursing staff will receive training that is standardized. 21 The test is copyrighted by the University of Toronto and there is a cost associated with its use. 21 The 
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Inclusion criteria

Types of participants
This review will consider studies that include adult patients screened for dysphagia (aged 18 years and over), who are admitted to an inpatient unit within a general acute care hospital setting. This review will consider studies that include dysphagia assessment using the Toronto Bedside Swallow Screening
Test and/or the 90-cc Water Swallow Screening Test. Studies with patients with active dysphagia and pneumonia present on admission will be excluded.
Focus of the review
This review will consider studies that assess oropharyngeal dysphagia in patients following an acute stroke, using the Toronto Bedside Dysphagia Screening test and/or the 90-cc Water Bedside Dysphagia Screening Test. In order to assess specificity and sensitivity, the screening tools will be compared against VF and FEES in diagnosing adults with dysphagia. Video-Fluoroscopy and FEES are the gold standard for identification of dysphagia and silent aspiration. This review will also investigate aspiration pneumonia as an adverse outcome for patients who underwent dysphagia screening tests.
Outcomes
Studies will be included that provide information about the diagnostic accuracy of the Toronto Bedside Dysphagia and 90-cc Water Bedside Dysphagia Screening tests to correctly identify dysphagia in adults following stroke. Outcomes include reliability (test re-test), validity (specificity and sensitivity), as well as
Positive Predictive Values (PPV) and Negative Predictive Values (NPV).
Types of studies
This review will consider any experimental study design including randomized controlled trials, non-randomized controlled trials, quasi-experimental, cohort studies, cross-sectional studies, case-controlled studies and observational studies, in which reliability and/or validity of the Toronto Bedside Swallowing Screening Test and the 90-cc Water Swallow is provided.
Search strategy
The search strategy aims to find both published and unpublished studies. A three-step search strategy will be utilized in this review. An initial search of MEDLINE and CINAHL will be undertaken, followed by analysis of the text words contained in the title and abstract, and of the index terms used to describe the article. A second search using all identified keywords and index terms will then be undertaken across all included databases. Thirdly, the reference lists of all identified reports and articles will be searched for additional studies. Studies published in English or translated into English will be considered for inclusion in this review. Studies published from 2007-2014 will be considered for inclusion in this review. The date chosen indicates the period in which studies were being conducted to assess the reliability, validity and clinical utility of various tools in order to identify a single evidence-based dysphagia-screening tool that could be used by frontline staff at the bedside.
The databases to be searched include:
PubMed, CINAHL and Cochrane Library
The search for unpublished studies will include: Initial keywords to be used will be: 
Assessment of methodological quality
Papers selected for retrieval will be assessed by two independent reviewers for methodological validity prior to inclusion in the review using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS) checklist (Appendix I). Any disagreements that arise between reviewers will be resolved through discussion, or with a third reviewer.
Data collection
Data will be extracted from papers included in the review using the standardized Standards for
Reporting of Diagnostic Accuracy (STARD) checklist (Appendix II). The data extraction will summarize key information from each study including information related to the participants' age and diagnosis, the settings, sample size and diagnostic intervention. The data extracted will include specific details about the interventions, populations, study methods and outcomes of significance to the review question and specific objectives. In situations where relevant study features are not provided within the study paper, the reviewer will contact the author to attempt to source additional information.
Data synthesis
Reliability and validity, including sensitivity, specificity, positive predictive value and negative predictive value will be extracted directly from the source papers. If this is not possible, values will be calculated from the data provided. Positive and negative likelihood ratios, diagnostic odds ratios and 95% confidence intervals will be calculated. The data will be displayed on Forest and ROC plots.
Heterogeneity will be assessed statistically using the standard Chi-square and also explored using subgroup analyses based on the different study designs included in this review. When synthesizing diagnostic outcomes, it is essential to plot sensitivity-specificity pairs for each included study. The relationship between the sensitivity-specificity pair depicts how significant heterogeneity differences exist and helps define the appropriate approach to synthesizing outcomes.
When statistical pooling is not possible, the findings will be presented in a narrative form including tables and figures to aid in data presentation where appropriate. If meta-analysis is possible, sensitivity and specificity scores will be pooled.
Rev Man 5.3 (Cochrane Collaboration) will be used as appropriate software to generate outcome measures and ROC plots.
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